Pharmacy at Biology Products
Pharmacy at Biology Technology
Pharmacy at Medicine News
A success for the Indian pharmacy: gets licence to manufacture Tamiflu
The anti flu treatment medicine acclaimed the world over Tamiflu now will be made in India. The licence has been given by Swiss firm Roche to make a generic version of its anti-flu treatment Tamiflu for India and other developing // countries. The company is Hetero Drugs. The drug is widely seen as the most promising treatment for combating any future pandemic of bird flu in humans....
Morning-After Pill At The Local Pharmacy Could Prevent Unwanted Pregnancies
A study published in the British Journal of Clinical Pharmacology states that 10% or more accidental and unwanted pregnancies could be prevented by providing morning-after pill at local pharmacies //as they have the advantage of easy access. UK researchers from South West Kent Primary Care Trust and the University of Bradford looked at 203 females aged from 13 to 20 who got the medicatio...
Pharmacy Board Says Pharmacists Have Right To Refuse Morning-After Pill
The state Board of
Pharmacy has voted to allow pharmacists to decline to sell morning-after emergency contraceptive in Washington//. But the governor, some lawmakers and women's rights organizations are furious with this decision. Rod Shafer, executive director of the Washington State
Pharmacy Association had said earlier this year that pharmacists should have the right to decline to...
Pharmacy Care Program Can Increase Medication Adherence in Elderly
Elderly patients will adhere more closely to their medication regimens if they have the benefit of a comprehensive
pharmacy// care program that includes patient education, specially packaged medications, and
pharmacy follow-up, according to a study. The “Federal Study of Adherence to Medications in the Elderly (FAME) Study,” funded by the American Society of Health-System Pharmacists...
Karnataka Pharmacy Gets Licence to Produce Medicines from White Arecanut
The Arecanut Research and Development Foundation at Mangalore in the southern Indian state of Karnataka has been granted licence for commercial manufacture of two Ayurvedic medicines using white arecanut.// <br...
More>>
Pharmacy at Medicine Products
IDENTI-SCAN Pharmacy
Description:Automated Patient ID and Medication Control System provides positive assurance that the correct medication is administered to the correct patient. It extends the benefits of the
pharmacy software to the bedside with positive verification and documentation of every medication transaction, creating an audit trail for reporting and charging....
Company:Bio-Logics Products, Inc.
Pharmacy at Medicine Technology
Pharmacyclics Announces Interim Results From Two Ongoing Phase 2
Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat
Recurrent Non-Small Cell Lung Cancer
WAILEA, Hawaii and SUNNYVALE, Calif., June 27, 2007/PRNewswire-FirstCall/ --
Pharmacyclics, Inc. today announcedpreliminary results from two open-label, multi-center Phase 2clinical trials supporting the potential use of Xcytrin(R)(motexafin gadolinium) Injection, the company's lead productcandidate, in combination with Alimta(R) (pemetrexed) and incombination with Taxotere(R) (docetaxel...
Pharmacyclics Announces Promising Results From Phase 2 Clinical
Trial of Xcytrin in Recurrent, Metastatic Non-Small Cell Lung
Cancer
- Data Support Rationale for Comprehensive Ongoing Phase 2 Programas Combination Agent with Standard Chemotherapies and Pivotal LungCancer Trial Scheduled to Begin Early Next Year - CHICAGO and SUNNYVALE, Calif. June 01, 2007/PRNewswire-FirstCall/ --
Pharmacyclics, Inc. today announcedpromising preliminary results from an open-label Phase 2 clinicaltrial of Xcytrin(R) (motexafin gadoliniu...
Pharmacyclics Announces Presentations and Published Abstracts on
Xcytrin at The 2007 American Society of Clinical Oncology Annual
Meeting
SUNNYVALE, Calif., May 23, 2007 /PRNewswire-FirstCall/ --
Pharmacyclics, Inc. announced today multiple presentations and apublished abstract regarding Xcytrin(R) (motexafin gadolinium)Injection, including an oral presentation of Phase 3 SMART (Studyof Neurologic Progression with Motexafin Gadolinium And RadiationTherapy) trial data. The presentations and publications are part ofthe procee...
Pharmacyclics Identifies Functional Biomarkers for its Novel HDAC
Inhibitor and Demonstrates Preclinical Anti-Tumor Activity with
Bruton's Tyrosine Kinase Inhibitors
SUNNYVALE, Calif. and LOS ANGELES, April 18, 2007/PRNewswire-FirstCall/ --
Pharmacyclics, Inc. today announced datafrom two preclinical studies, one identifying a functionalbiomarker for its novel histone deacetylase (HDAC) inhibitor andanother demonstrating preclinical anti-tumor activity with itsBruton's tyrosine kinase (BTK) inhibitor compounds. The data werepresented at the American...
Pharmacyclics Announces Presentations on Its Novel and Selective
HDAC and Bruton's Tyrosine Kinase Inhibitor Compounds
SUNNYVALE, Calif., April 11, 2007 /PRNewswire-FirstCall/ --
Pharmacyclics, Inc. announced today multiple presentationsregarding its novel histone deacetylase (HDAC) inhibitor andBruton's tyrosine kinase inhibitor compounds. The presentationswill take place at the American Association for Cancer Research(AACR) 2007 Annual Meeting being held April 14-18, 2007, at the LosAngeles Convention C...